192 related articles for article (PubMed ID: 26523632)
1. Noncovalent PEGylation, An Innovative Subchapter in the Field of Protein Modification.
Reichert C; Borchard G
J Pharm Sci; 2016 Feb; 105(2):386-390. PubMed ID: 26523632
[TBL] [Abstract][Full Text] [Related]
2. Noncovalent PEGylation of L-asparaginase using PEGylated polyelectrolyte.
Kurinomaru T; Shiraki K
J Pharm Sci; 2015 Feb; 104(2):587-92. PubMed ID: 25354692
[TBL] [Abstract][Full Text] [Related]
3. Pegylation: a novel process for modifying pharmacokinetics.
Harris JM; Martin NE; Modi M
Clin Pharmacokinet; 2001; 40(7):539-51. PubMed ID: 11510630
[TBL] [Abstract][Full Text] [Related]
4. The impact of PEGylation on biological therapies.
Veronese FM; Mero A
BioDrugs; 2008; 22(5):315-29. PubMed ID: 18778113
[TBL] [Abstract][Full Text] [Related]
5. Effects of pharmaceutical PEGylation on drug metabolism and its clinical concerns.
Zhang X; Wang H; Ma Z; Wu B
Expert Opin Drug Metab Toxicol; 2014 Dec; 10(12):1691-702. PubMed ID: 25270687
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Site-Specific PEGylation of Fibroblast Growth Factor 2 Facilitates Rational Selection of Conjugate Sites.
Zhao J; Li Q; Wu J; Zhou C; Cao Y; Li X; Niu J
Biotechnol J; 2020 Feb; 15(2):e1900203. PubMed ID: 31556248
[TBL] [Abstract][Full Text] [Related]
7. N-terminal specificity of PEGylation of human bone morphogenetic protein-2 at acidic pH.
Hu J; Sebald W
Int J Pharm; 2011 Jul; 413(1-2):140-6. PubMed ID: 21539904
[TBL] [Abstract][Full Text] [Related]
8. Noncovalent PEGylation of protein and peptide therapeutics.
Andrianov AK
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1897. PubMed ID: 37138514
[TBL] [Abstract][Full Text] [Related]
9. Chemical and enzymatic site specific PEGylation of hGH.
da Silva Freitas D; Mero A; Pasut G
Bioconjug Chem; 2013 Mar; 24(3):456-63. PubMed ID: 23432141
[TBL] [Abstract][Full Text] [Related]
10. Protein carboxyl amidation increases the potential extent of protein polyethylene glycol conjugation.
Li S; Yang Z; Sun X; Tan Y; Yagi S; Hoffman RM
Anal Biochem; 2004 Jul; 330(2):264-71. PubMed ID: 15203332
[TBL] [Abstract][Full Text] [Related]
11. Pegylation: engineering improved biopharmaceuticals for oncology.
Molineux G
Pharmacotherapy; 2003 Aug; 23(8 Pt 2):3S-8S. PubMed ID: 12921216
[TBL] [Abstract][Full Text] [Related]
12. Supramolecular PEGylation of biopharmaceuticals.
Webber MJ; Appel EA; Vinciguerra B; Cortinas AB; Thapa LS; Jhunjhunwala S; Isaacs L; Langer R; Anderson DG
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14189-14194. PubMed ID: 27911829
[TBL] [Abstract][Full Text] [Related]
13. PEGylation and its impact on the design of new protein-based medicines.
Ginn C; Khalili H; Lever R; Brocchini S
Future Med Chem; 2014; 6(16):1829-46. PubMed ID: 25407370
[TBL] [Abstract][Full Text] [Related]
14. Effect of PEG molecular weight and PEGylation degree on the physical stability of PEGylated lysozyme.
Morgenstern J; Baumann P; Brunner C; Hubbuch J
Int J Pharm; 2017 Mar; 519(1-2):408-417. PubMed ID: 28130198
[TBL] [Abstract][Full Text] [Related]
15. Novel Bioconjugation Strategy Using Elevated Hydrostatic Pressure: A Case Study for the Site-Specific Attachment of Polyethylene Glycol (PEGylation) of Recombinant Human Ciliary Neurotrophic Factor.
Wang Q; Zhang C; Guo F; Li Z; Liu Y; Su Z
Bioconjug Chem; 2017 Nov; 28(11):2841-2848. PubMed ID: 29053917
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic protein-polymer conjugates: advancing beyond PEGylation.
Pelegri-O'Day EM; Lin EW; Maynard HD
J Am Chem Soc; 2014 Oct; 136(41):14323-32. PubMed ID: 25216406
[TBL] [Abstract][Full Text] [Related]
17. Site-specific PEGylation of a mutated-cysteine residue and its effect on tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL).
Pan LQ; Wang HB; Lai J; Xu YC; Zhang C; Chen SQ
Biomaterials; 2013 Dec; 34(36):9115-23. PubMed ID: 23981355
[TBL] [Abstract][Full Text] [Related]
18. PEGylation of cytokines and other therapeutic proteins and peptides: the importance of biological optimisation of coupling techniques.
Francis GE; Fisher D; Delgado C; Malik F; Gardiner A; Neale D
Int J Hematol; 1998 Jul; 68(1):1-18. PubMed ID: 9713164
[TBL] [Abstract][Full Text] [Related]
19. Influence of PEGylation on the Strength of Protein Surface Salt Bridges.
Xiao Q; Draper SRE; Smith MS; Brown N; Pugmire NAB; Ashton DS; Carter AJ; Lawrence EEK; Price JL
ACS Chem Biol; 2019 Jul; 14(7):1652-1659. PubMed ID: 31188563
[TBL] [Abstract][Full Text] [Related]
20. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
